Equities Analysts Offer Predictions for TCRX FY2024 Earnings
TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) – Stock analysts at Wedbush increased their FY2024 earnings per share estimates for shares of TScan Therapeutics in a report released on Tuesday, November 12th. Wedbush analyst D. Nierengarten now anticipates that the company will earn ($1.09) per share for the year, up from their previous forecast of […]
15 Nov 11:04 · The Markets Daily